Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
2003 StandoutScience
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Glutamate and GABA receptor signalling in the developing brain
2004
Contribution of platelets to tumour metastasis
2011 Standout
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
2013 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
New treatment for acute myelogenous leukemia
2014
Perioperative Management of Antithrombotic Therapy
2012 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center
2011
Stereotypical Physiological Properties Emerge During Early Neuronal and Glial Lineage Development in the Embryonic Rat Neocortex
2000
Antithrombotic Therapy for VTE Disease
2016 Standout
Hepatocellular carcinoma
2021 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Neurogenic Radial Glial Cells in Reptile, Rodent and Human: from Mitosis to Migration
2003
Neonatal loss of γ–aminobutyric acid pathway expression after human perinatal brain injury
2006
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Excitatory GABA Action Is Essential for Morphological Maturation of Cortical NeuronsIn Vivo
2007
Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances
2008 Standout
Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors
2005 Standout
Executive Summary
2012 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
2019
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
2011 Standout
The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells
2003
The promise of Janus kinase inhibitors in the treatment of hematological malignancies
2016
Thrombosis and cancer
2012
Postnatal concerns in children born to women with epilepsy
2007
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
2013 Standout
The Neurobiological Context of Autism
2003
A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
2014
Excitatory actions of gaba during development: the nature of the nurture
2002 Standout
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
The future of epigenetic therapy in solid tumours—lessons from the past
2013
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Management of MPN beyond JAK2
2014
Management of glioblastoma: State of the art and future directions
2020 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Acute Myeloid Leukemia
2015 Standout
Incidental Detection of Pulmonary Emboli on Routine MDCT of the Chest
2005
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Hypomethylating agent combination strategies in myelodysplastic syndromes: hopes and shortcomings
2016
Cancer, Clots and Consensus: New Understanding of an Old Problem
2009
GABA Expression Dominates Neuronal Lineage Progression in the Embryonic Rat Neocortex and Facilitates Neurite Outgrowth via GABAAAutoreceptor/Cl−Channels
2001
The emerging role of immune checkpoint based approaches in AML and MDS
2017 StandoutNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The Glial Nature of Embryonic and Adult Neural Stem Cells
2009 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
How I treat refractory and early relapsed acute myeloid leukemia
2015
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure
2016
Changing Properties of GABAAReceptor–Mediated Signaling During Early Neocortical Development
1999
Autismo e doenças invasivas de desenvolvimento
2004 Standout
Works of Casey L. O’Connell being referenced
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
2015
Incidental venous thromboembolism in oncology patients
2012
Approach to the Management of Incidental Venous Thromboembolic Events in Patients With Cancer
2014
Emerging treatment options for myelofibrosis: focus on pacritinib
2016
Experience with pegylated interferon -2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients
2012
Abstract LB-214: Interim results from a randomized Phase 1-2 first-in-human (FIH) study of PK/PD guided escalating doses of SGI-110, a novel subcutaneous (SQ) second generation hypomethylating agent (HMA) in relapsed/refractory MDS and AML
2012
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI‐110) in Hepatocellular Carcinoma
2018
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi‐row detector computed tomography scanning
2010
International Randomized Phase III Study of Elacytarabine Versus Investigator Choice in Patients With Relapsed/Refractory Acute Myeloid Leukemia
2014
Low-molecular-weight heparins in the prevention and management of malignancy-related venous thromboembolism
2006
Differential Response of Cortical Plate and Ventricular Zone Cells to GABA as a Migration Stimulus
1998
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial
2020
Unsuspected Pulmonary Emboli in Cancer Patients: Clinical Correlates and Relevance
2006